Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney Function
Abstract
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are capable of inducing a variety of renal function abnormalities, particularly in high‐risk patients with decreased renal blood perfusion who depend on prostaglandin synthesis to maintain normal renal function. Fluid retention is the most common NSAID‐related renal complication, occurring to some degree in virtually all exposed individuals; however, clinically detectable edema occurs in less than 5% of patients and is readily reversible on discontinuation of the NSAID. Other electrolyte complications, notably hyperkalemia, are seen infrequently and occur in specific at‐risk patients. The next most worrisome complication is acute deterioration of renal function, which occurs in high‐risk patients and is also reversible. Nephrotic syndrome with interstitial nephritis is a rare problem of NSAID use and is reversible. Papillary necrosis is the only permanent complication of NSAIDs and is very rare. Altogether, these renal function abnormalities, with the exception of mild fluid retention, are clinically detectable in approximately 1% of exposed patients. Given the number of patients who take NSAIDs on a prescription or over‐the‐counter basis, the absolute number of at‐risk patients is relatively large. Consequently, an appreciation for the risk factors and pathophysiology of NSAID‐induced renal function abnormalities is required for optimal use of these drugs.
Citing Literature
Number of times cited according to CrossRef: 193
- Megan Baker, Mark A. Perazella, NSAIDs in CKD: Are They Safe?, American Journal of Kidney Diseases, 10.1053/j.ajkd.2020.03.023, (2020).
- Scott D. Cohen, Sara N. Davison, Paul L. Kimmel, Pain and Chronic Kidney Disease, Chronic Renal Disease, 10.1016/B978-0-12-815876-0.00078-4, (1279-1289), (2020).
- Maike Scherf-Clavel, Susanne Treiber, Jürgen Deckert, Stefan Unterecker, Leif Hommers, Drug-Drug Interactions Between Lithium and Cardiovascular as Well as Anti-Inflammatory Drugs, Pharmacopsychiatry, 10.1055/a-1157-9433, 53, 05, (229), (2020).
- Michael H. Pillinger, Brian F. Mandell, Therapeutic approaches in the treatment of gout, Seminars in Arthritis and Rheumatism, 10.1016/j.semarthrit.2020.04.010, 50, 3, (S24-S30), (2020).
- Justin Chen, David Salerno, Nadine Breslin, Tasnim Chowdhury, Steven Lobritto, Mercedes Martinez, Dana Goldner, Jennifer Vittorio, Concomitant tacrolimus and ketorolac therapy in pediatric liver transplant recipients: Teaching old dogma new tricks, Clinical Transplantation, 10.1111/ctr.14141, 0, 0, (2020).
- Sheeba Khan, Faiz Noor Khan Yusufi, Ahad Noor Khan Yusufi, Comparative effect of Indomethacin (IndoM) on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in the kidney, small intestine and liver of rats, Toxicology Reports, 10.1016/j.toxrep.2019.04.010, (2019).
- Eva Espinosa-Cano, María Rosa Aguilar, Blanca Vázquez, Julio San Román, Inflammation-Responsive Polymers, Smart Polymers and their Applications, 10.1016/B978-0-08-102416-4.00007-7, (219-254), (2019).
- Manikanta Murahari, Vivek Mahajan, Sreenivasulu Neeladri, Maushmi S Kumar, Y.C. Mayur, Ligand based Design and Synthesis of Pyrazole Based Derivatives as Selective COX-2 Inhibitors, Bioorganic Chemistry, 10.1016/j.bioorg.2019.02.031, (2019).
- Sriram Sriperumbuduri, Swapnil Hiremath, The case for cautious consumption, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0000000000000473, 28, 2, (163-170), (2019).
- Viviane Khalil, Wei Wang, Lauren Charlson, Samantha Blackley, Evaluation of prescribing patterns of nonsteroidal anti-inflammatory agents in a tertiary setting, International Journal of Evidence-Based Healthcare, 10.1097/XEB.0000000000000173, 17, 3, (164-172), (2019).
- Amy Barton Pai, Holly Divine, Macary Marciniak, Anthony Morreale, Joseph J. Saseen, Kenneth Say, Alissa R. Segal, Jenna M. Norton, Andrew S. Narva, Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury, Annals of Pharmacotherapy, 10.1177/1060028018789174, 53, 1, (95-100), (2018).
- Bruce M Rothschild, Maligned non-steroidal anti-inflammatory drugs: Misunderstanding of their safety profile in patients with renal insufficiency, World Journal of Rheumatology, 10.5499/wjr.v8.i1.1, 8, 1, (1-4), (2018).
- Jessica M. Hooper, Benjamin S. Kester, Ran Schwarzkopf, Low rates of renal injury in total joint arthroplasty patients without pre-existing renal disease, Arthroplasty Today, 10.1016/j.artd.2017.12.007, (2018).
- Tyler Woodell, Rupali S. Avasare, Nephrotoxicity of Select Rheumatologic Drugs, Rheumatic Disease Clinics of North America, 10.1016/j.rdc.2018.06.005, 44, 4, (605-617), (2018).
- Bryan S. Williams, Nonopioid Analgesics, Essentials of Pain Medicine, 10.1016/B978-0-323-40196-8.00051-6, (457-468.e2), (2018).
- Sangkwan Lee, Seon-jong Kim, Efficacy and safety of ChondroT on knee-osteoarthritis, Medicine, 10.1097/MD.0000000000010170, 97, 12, (e0170), (2018).
- Megan L. Sulciner, Allison Gartung, Molly M. Gilligan, Charles N. Serhan, Dipak Panigrahy, Targeting lipid mediators in cancer biology, Cancer and Metastasis Reviews, 10.1007/s10555-018-9754-9, 37, 2-3, (557-572), (2018).
- André E. Bussières, Gregory Stewart, Fadi Al-Zoubi, Philip Decina, Martin Descarreaux, Danielle Haskett, Cesar Hincapié, Isabelle Pagé, Steven Passmore, John Srbely, Maja Stupar, Joel Weisberg, Joseph Ornelas, Spinal Manipulative Therapy and Other Conservative Treatments for Low Back Pain: A Guideline From the Canadian Chiropractic Guideline Initiative, Journal of Manipulative and Physiological Therapeutics, 10.1016/j.jmpt.2017.12.004, 41, 4, (265-293), (2018).
- Jaismy Jacob P, S.L. Manju, K.R. Ethiraj, Geetha Elias, Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach, European Journal of Pharmaceutical Sciences, 10.1016/j.ejps.2018.06.003, 121, (356-381), (2018).
- Misa Naganuma, Yumi Motooka, Sayaka Sasaoka, Haruna Hatahira, Shiori Hasegawa, Akiho Fukuda, Satoshi Nakao, Kazuyo Shimada, Koseki Hirade, Takayuki Mori, Tomoaki Yoshimura, Takeshi Kato, Mitsuhiro Nakamura, Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database, SAGE Open Medicine, 10.1177/2050312118772475, 6, (205031211877247), (2018).
- Matthias G. Hautmann, Ernst-Michael Jung, Lukas P. Beyer, Christoph Süß, Felix Steger, Markus Weber, Fabian Pohl, Oliver Kölbl, Franz Josef Putz, Is low dose radiotherapy an effective treatment for Baker’s cyst?Ist die Strahlentherapie eine effektive Behandlungsoption der Bakerzyste?, Strahlentherapie und Onkologie, 10.1007/s00066-018-1389-9, (2018).
- Jiayu Ye, Sanjoy Ghosh, Omega-3 PUFA vs. NSAIDs for Preventing Cardiac Inflammation, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2018.00146, 5, (2018).
- Kuriakose Jayesh, Raj Karishma, A. Vysakh, Prasad Gopika, M. S. Latha, Terminalia bellirica (Gaertn.) Roxb fruit exerts anti-inflammatory effect via regulating arachidonic acid pathway and pro-inflammatory cytokines in lipopolysaccharide-induced RAW 264.7 macrophages, Inflammopharmacology, 10.1007/s10787-018-0513-x, (2018).
- Louis Jacob, Karel Kostev, Prevalence of pain medication prescriptions in France, Germany, and the UK - a cross-sectional study including 4,270,142 patients, Postgraduate Medicine, 10.1080/00325481.2018.1391658, 130, 1, (32-36), (2017).
- Jordan Brand, Sedation and Analgesia, Pharmaceutical Sciences, 10.4018/978-1-5225-1762-7, (486-519), (2017).
- Xu Wang, Qinghua Wu, Aimei Liu, Arturo Anadón, José-Luis Rodríguez, María-Rosa Martínez-Larrañaga, Zonghui Yuan, María-Aránzazu Martínez, Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro , Drug Metabolism Reviews, 10.1080/03602532.2017.1354014, 49, 4, (395-437), (2017).
- WL. Baker, NSAIDs and Cardiovascular Toxicity ☆, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.95640-X, (2017).
- Choochai Teerawattananon, Pongchirat Tantayakom, Bundarika Suwanawiboon, Wanruchada Katchamart, Risk of perioperative bleeding related to highly selective cyclooxygenase-2 inhibitors: A systematic review and meta-analysis, Seminars in Arthritis and Rheumatism, 10.1016/j.semarthrit.2016.07.008, 46, 4, (520-528), (2017).
- Sheryl L Follin, Scott L Charland, Acute Pain Management: Operative or Medical Procedures and Trauma, Annals of Pharmacotherapy, 10.1177/106002809703100917, 31, 9, (1068-1076), (2017).
- M Donald Mcgoldrick, George R Bailie, Nonnarcotic Analgesics: Prevalence and Estimated Economic Impact of Toxicities, Annals of Pharmacotherapy, 10.1177/106002809703100214, 31, 2, (221-227), (2017).
- Brittany Albrecht, Shelley Giebel, Michelle McCarron, Bhanu Prasad, Cyclooxygenase-2 inhibitor-induced acute interstitial nephritis, BMJ Case Reports, 10.1136/bcr-2017-219973, (bcr-2017-219973), (2017).
- Laura Prieto-García, Miguel Pericacho, Sandra M. Sancho-Martínez, Ángel Sánchez, Carlos Martínez-Salgado, José Miguel López-Novoa, Francisco J. López-Hernández, Mechanisms of triple whammy acute kidney injury, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2016.07.011, 167, (132-145), (2016).
- Souraya Domiati, Ahmed El-Mallah, Asser Ghoneim, Adnan Bekhit, Heba Abd El Razik, Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives, Inflammopharmacology, 10.1007/s10787-016-0270-7, 24, 4, (163-172), (2016).
- A. Iwamura, K. Watanabe, S. Akai, T. Nishinosono, K. Tsuneyama, S. Oda, T. Kume, T. Yokoi, Zomepirac Acyl Glucuronide Is Responsible for Zomepirac-Induced Acute Kidney Injury in Mice, Drug Metabolism and Disposition, 10.1124/dmd.116.069575, 44, 7, (888-896), (2016).
- Fred G. Silva, Chemical-Induced Nephropathy: A Review of the Renal Tubulointerstitial Lesions in Humans, Toxicologic Pathology, 10.1080/01926230490457530, 32, 2_suppl, (71-84), (2016).
- Melanie S. Joy, The Renal Effects of Traditional Nonsteroidal Anti-Inflammatory Agents Versus Cyclooxygenase-2 Inhibitors, Journal of Pharmacy Practice, 10.1177/089719002237254, 15, 5, (383-391), (2016).
- Jill W. Verlander, Normal Ultrastructure of the Kidney and Lower Urinary Tract, Toxicologic Pathology, 10.1177/019262339802600101, 26, 1, (1-17), (2016).
- Peter H. Bach, Nguyen Thi Kim Thanh, Renal Papillary Necrosis—40 Years On, Toxicologic Pathology, 10.1177/019262339802600110, 26, 1, (73-91), (2016).
- Kanwar Nasir M. Khan, Catherine M. Venturini, Roderick T. Bunch, Jacquline A. Brassard, Alane T. Koki, Dale L. Morris, Benjamin E. Trump, Timothy J. Maziasz, Carl L. Alden, Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal Antiinflammatory Drug-Related Nephrotoxicity, Toxicologic Pathology, 10.1177/019262339802600504, 26, 5, (612-620), (2016).
- Kanwar Nasir M. Khan, Carl L. Alden, Stephanie E. Gleissner, Mary K. Gessford, Timothy J. Maziasz, Effect of Papillotoxic Agents on Expression of Cyclooxygenase Isoforms in the Rat Kidney, Toxicologic Pathology, 10.1177/019262339802600116, 26, 1, (137-142), (2016).
- Jordan Brand, Sedation and Analgesia, Modern Concepts and Practices in Cardiothoracic Critical Care, 10.4018/978-1-4666-8603-8.ch012, (278-312), (2015).
- Scott D. Cohen, Sara Davison, Pain and Chronic Kidney Disease, Chronic Renal Disease, 10.1016/B978-0-12-411602-3.00071-8, (854-860), (2015).
- Nadya E. York, Michael S. Borofsky, James E. Lingeman, Risks associated with drug treatments for kidney stones, Expert Opinion on Drug Safety, 10.1517/14740338.2015.1100604, 14, 12, (1865-1877), (2015).
- E. Venkateshwarlu, B. S. Sharvana Bhava, R. Shiva Kumar, Rao J. Venkateshwar, E. Gouthami, K. Umasankar, Evaluation of diuretic activity of Syzygium cumini and its effect on prostaglandin system, Oriental Pharmacy and Experimental Medicine, 10.1007/s13596-015-0179-5, 15, 1, (45-51), (2015).
- Ming-Zhi Zhang, Bing Yao, Yinqiu Wang, Shilin Yang, Suwan Wang, Xiaofeng Fan, Raymond C. Harris, Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension, Journal of Clinical Investigation, 10.1172/JCI81550, 125, 11, (4281-4294), (2015).
- H. Richard Barthel, Robert A. Axford-Gatley, Topical Nonsteroidal Anti-Inflammatory Drugs for Osteoarthritis, Postgraduate Medicine, 10.3810/pgm.2010.11.2227, 122, 6, (98-106), (2015).
- Dawn A. Marcus, Tips for managing chronic pain, Postgraduate Medicine, 10.3810/pgm.2003.04.1400, 113, 4, (49-98), (2015).
- Brett R. Stacey, Effective management of chronic pain, Postgraduate Medicine, 10.3810/pgm.1996.09.82, 100, 3, (281-296), (2015).
- Huiwen Ren, Baoxue Yang, Patrick A. Molina, Jeff M. Sands, Janet D. Klein, NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip, PLOS ONE, 10.1371/journal.pone.0141714, 10, 10, (e0141714), (2015).
- Sidhartha Deshmukh, Harmanjit Singh Banga, Nittin Dev Singh, Rajinder Singh Brar, Renal pathology associated with kidney stones in two buffaloes, Veterinary Medicine and Animal Sciences, 1072432054342531, 3, 1, (1), (2015).
- Diane Cappelletty, Alyse Jablonski, Rose Jung, Risk Factors for Acute Kidney Injury in Adult Patients Receiving Vancomycin, Clinical Drug Investigation, 10.1007/s40261-013-0163-0, 34, 3, (189-193), (2014).
- M.J. Johnston, J.E.F. Fitzgerald, A. Bhangu, N.S. Greaves, C.L. Prew, I. Fraser, Outpatient management of biliary colic: A prospective observational study of prescribing habits and analgesia effectiveness, International Journal of Surgery, 10.1016/j.ijsu.2013.12.003, 12, 2, (169-176), (2014).
- Ian M Rawe, The case for over-the-counter shortwave therapy: safe and effective devices for pain management, Pain Management, 10.2217/pmt.13.60, 4, 1, (37-43), (2014).
- Martin Wehling, Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects, European Journal of Clinical Pharmacology, 10.1007/s00228-014-1734-6, 70, 10, (1159-1172), (2014).
- K. E. Truitt, R. S. Sperling, W. H. Ettinger, M. Greenwald, L. DeTora, Q. Zeng, J. Bolognese, E. Ehrich, A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis, Aging Clinical and Experimental Research, 10.1007/BF03351533, 13, 2, (112-121), (2014).
- W. W. A. Zuurmond, Pain Treatment With NSAIDs, Primary Focus on Ibuprofen, Clinical Rheumatology, 10.1007/BF03342661, 20, S1, (6-8), (2014).
- Ylenia Ingrasciotta, Janet Sultana, Francesco Giorgianni, Achille Patrizio Caputi, Vincenzo Arcoraci, Daniele Ugo Tari, Claudio Linguiti, Margherita Perrotta, Andrea Nucita, Fabio Pellegrini, Andrea Fontana, Lorenzo Cavagna, Domenico Santoro, Gianluca Trifirò, The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy, PLoS ONE, 10.1371/journal.pone.0089072, 9, 2, (e89072), (2014).
- Syed Uzair A. Shah, Huma Jawed, Shahid I. Awan, Shazia Anjum, Shabana U. Simjee, The Anti-Arthritic and Immune-Modulatory Effects of NHAG: A Novel Glucosamine Analogue in Adjuvant-Induced Arthritis, BioMed Research International, 10.1155/2013/487610, 2013, (1-13), (2013).
- Rosanna Di Paola, Tiziana Genovese, Daniela Impellizzeri, Akbar Ahmad, Salvatore Cuzzocrea, Emanuela Esposito, The renal injury and inflammation caused by ischemia–reperfusion are reduced by genetic inhibition of TNF-αR1: A comparison with infliximab treatment, European Journal of Pharmacology, 10.1016/j.ejphar.2012.11.066, 700, 1-3, (134-146), (2013).
- Timothy F. Platts-Mills, Natalie L. Richmond, Katherine M. Hunold, C. Barrett Bowling, Life-threatening hyperkalemia after 2 days of ibuprofen, The American Journal of Emergency Medicine, 10.1016/j.ajem.2012.09.002, 31, 2, (465.e1-465.e2), (2013).
- Hang-Sik Roh, Jong-Kwon Lee, Tae-Sung Kim, Ji-Hyeon Seok, Ji-Hyun Yun, Ji-Young Yun, Saet-Byul Oh, Soon-Young Han, Jayoung Jeong, Classification of Nephrotoxicants, Kidney, 10.1201/b15476, (191-203), (2013).
- Raymond A. Dionne, Duncan Haynes, Jaime S. Brahim, Janet S. Rowan, Pol‐Henri Guivarc'h, Analgesic Effect of Sustained‐Release Flurbiprofen Administered at the Site of Tissue Injury in the Oral Surgery Model, The Journal of Clinical Pharmacology, 10.1177/0091270004265703, 44, 12, (1418-1424), (2013).
- Raymond A. Dionne, Sharon M. Gordon, Martin Tahara, Janet Rowan, Emanuel Troullos, Analgesic Efficacy and Pharmacokinetics of Ketoprofen Administered into a Surgical Site, The Journal of Clinical Pharmacology, 10.1177/00912709922007679, 39, 2, (131-138), (2013).
- Angela Cheng, William H. Frishman, Use of Angiotensin‐Converting Enzyme Inhibitors as Monotherapy and in Combination with Diuretics and Calcium Channel Blockers, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1998.tb05784.x, 38, 6, (477-491), (2013).
- Andrew Whelton, Renal Effects of Over‐the‐Counter Analgesics, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1995.tb04088.x, 35, 5, (454-463), (2013).
- John C. Somberg, Hector Gomez, Andrew Whelton, Clinical Therapeutic Conference, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1991.tb01911.x, 31, 9, (785-791), (2013).
- I. Wulff, F. Könner, M. Kölzsch, A. Budnick, D. Dräger, R. Kreutz, Interdisziplinäre Handlungsempfehlung zum Management von Schmerzen bei älteren Menschen in PflegeheimenInterdisciplinary guidance for pain management in nursing home residents, Zeitschrift für Gerontologie und Geriatrie, 10.1007/s00391-012-0332-4, 45, 6, (505-544), (2012).
- Wenjun Ju, Shahaan Smith, Matthias Kretzler, Genomic biomarkers for chronic kidney disease, Translational Research, 10.1016/j.trsl.2012.01.020, 159, 4, (290-302), (2012).
- Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir, Renal Consequences of Prostaglandin Inhibition in Heart Failure, The Kidney in Heart Failure, 10.1007/978-1-4614-3694-2, (117-125), (2012).
- J E Wyatt, W L Pettit, S Harirforoosh, Pharmacogenetics of nonsteroidal anti-inflammatory drugs, The Pharmacogenomics Journal, 10.1038/tpj.2012.40, 12, 6, (462-467), (2012).
- Bruce P. Burnett, Robert M. Levy, 5-Lipoxygenase Metabolic Contributions to NSAID-Induced Organ Toxicity, Advances in Therapy, 10.1007/s12325-011-0100-7, 29, 2, (79-98), (2012).
- David Bennett, Siti Mariam bt Zainal Ariffin, Pamela Johnston, Osteoarthritis in the cat, Journal of Feline Medicine and Surgery, 10.1177/1098612X11432829, 14, 1, (76-84), (2012).
- C. Guidon, Alteraciones de la potasemia en el adulto, EMC - Anestesia-Reanimación, 10.1016/S1280-4703(12)60582-9, 38, 1, (1-15), (2012).
- A. Chapagain, N. Ashman, Hyperkalaemia in the age of aldosterone antagonism, QJM, 10.1093/qjmed/hcs106, 105, 11, (1049-1057), (2012).
- Jean-Philippe Lafrance, Donald R. Miller, Dispensed Selective and Nonselective Nonsteroidal Anti-inflammatory Drugs and the Risk of Moderate to Severe Hyperkalemia: A Nested Case-Control Study, American Journal of Kidney Diseases, 10.1053/j.ajkd.2012.02.328, 60, 1, (82-89), (2012).
- Harpal S. Khanuja, Marc W. Hungerford, Stephen R. Thompson, Maria S. Goddard, Michael A. Mont, Nonoperative Treatment of Knee Arthritis, Insall & Scott Surgery of the Knee, 10.1016/B978-1-4377-1503-3.00092-5, (896-908), (2012).
- Martin H. de Borst, Ferdau L. Nauta, Liffert Vogt, Gozewijn D. Laverman, Ron T. Gansevoort, Gerjan Navis, Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis, PLoS ONE, 10.1371/journal.pone.0037957, 7, 5, (e37957), (2012).
- Marganit Cohen-Avrahami, Dima Libster, Abraham Aserin, Nissim Garti, Sodium Diclofenac and Cell-Penetrating Peptides Embedded in H II Mesophases: Physical Characterization and Delivery , The Journal of Physical Chemistry B, 10.1021/jp112067v, 115, 34, (10189-10197), (2011).
- Christoph Küper, Helmut Bartels, Franz-X. Beck, Wolfgang Neuhofer, Cyclooxygenase-2-dependent phosphorylation of the pro-apoptotic protein Bad inhibits tonicity-induced apoptosis in renal medullary cells, Kidney International, 10.1038/ki.2011.199, 80, 9, (938-945), (2011).
- Norman T. Ilowite, Ronald M. Laxer, PHARMACOLOGY AND DRUG THERAPY, Textbook of Pediatric Rheumatology, 10.1016/B978-1-4160-6581-4.10006-8, (71-126), (2011).
- K. W. Moon, J. Kim, J. H. Kim, R. Song, E. Y. Lee, Y. W. Song, E. B. Lee, Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemia, Rheumatology, 10.1093/rheumatology/ker286, 50, 12, (2278-2282), (2011).
- Wade W. Benton, Adam W. Brothers, Christa C. Jefferis Kirk, Gretchen A. Linggi Irby, Christopher M. Rubino, Adverse Drug Reactions and Drug-drug Interactions, Pediatric Critical Care, 10.1016/B978-0-323-07307-3.10118-1, (1569-1589), (2011).
- C. Guidon, Dyskaliémies de l'adulte, EMC - Anesthésie-Réanimation, 10.1016/S0246-0289(11)44765-4, 8, 4, (1-15), (2011).
- Emanuela Esposito, Stefania Mondello, Rosanna Di Paola, Emanuela Mazzon, Domenico Italiano, Irene Paterniti, Patrizia Mondello, Carmela Aloisi, Salvatore Cuzzocrea, Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats, Naunyn-Schmiedeberg's Archives of Pharmacology, 10.1007/s00210-011-0610-5, 383, 5, (493-508), (2011).
- M Capuzzo, S Carrer, A Sgarbi, M Verri, R Alvisi, G Gritti, The effect of single-dose non-steroidal anti-inflammatory drugs on urinary output, Clinical Intensive Care, 10.3109/tcic.10.2.55.60, 10, 2, (55-60), (2011).
- J.B. Tarloff, Analgesics and Nonsteroidal Anti-Inflammatory Drugs, Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00821-6, (387-403), (2010).
- C.L. Léos, NSAIDs and Cardiovascular Toxicity, Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00716-8, (323-336), (2010).
- Kathrine F. Vandraas, Olav Spigset, Milada Mahic, Lars Slørdal, Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly, European Journal of Clinical Pharmacology, 10.1007/s00228-010-0825-2, 66, 8, (823-829), (2010).
- Michael L. Bentley, Howard L. Corwin, Joseph Dasta, Drug-induced acute kidney injury in the critically ill adult: Recognition and prevention strategies, Critical Care Medicine, 10.1097/CCM.0b013e3181de0c60, 38, (S169-S174), (2010).
- Vincent E. Friedewald, Joel S. Bennett, J. Paul Christo, James L. Pool, James M. Scheiman, Lee S. Simon, Vibeke Strand, William B. White, Gary W. Williams, William C. Roberts, AJC Editor's Consensus: Selective and Nonselective Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Risk, The American Journal of Cardiology, 10.1016/j.amjcard.2010.04.006, 106, 6, (873-884), (2010).
- Arthur G. Lipman, A Call for Rational and Cost-Effective NSAID Therapy , Journal of Pharmaceutical Care in Pain & Symptom Control, 10.1300/J088v02n02_05, 2, 2, (39-46), (2010).
- ROY D. ALTMAN, RENÉE-LILIANE DREISER, CHESTER L. FISHER, WALTER F. CHASE, DONATUS S. DREHER, JOSEF ZACHER, Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled Trial, The Journal of Rheumatology, 10.3899/jrheum.081316, 36, 9, (1991-1999), (2009).
- Sam Harirforoosh, Fakhreddin Jamali, Renal adverse effects of nonsteroidal anti-inflammatory drugs, Expert Opinion on Drug Safety, 10.1517/14740330903311023, 8, 6, (669-681), (2009).
- Arquimedes Gasparotto, Marcos Aurelio Boffo, Emerson Luiz Botelho Lourenço, Maria Elida Alves Stefanello, Cândida Aparecida Leite Kassuya, Maria Consuelo Andrade Marques, Natriuretic and diuretic effects of Tropaeolum majus (Tropaeolaceae) in rats, Journal of Ethnopharmacology, 10.1016/j.jep.2009.01.021, 122, 3, (517-522), (2009).
- P.-C. T. Pham, E. Toscano, P.-M. T. Pham, P.-A. T. Pham, S. V. Pham, P.-T. T. Pham, Pain management in patients with chronic kidney disease, Clinical Kidney Journal, 10.1093/ndtplus/sfp001, 2, 2, (111-118), (2009).
- P. P. Geusens, K. Truitt, P. Sfikakis, P. L. Zhao, L. Detora, S. Shingo, C. S. Lau, A. Kalla, G. Tate, A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis, Scandinavian Journal of Rheumatology, 10.1080/030097402320318431, 31, 4, (230-238), (2009).
- Efstathios Alexopoulos, Drug-Induced Acute Interstitial Nephritis, Renal Failure, 10.3109/08860229809045178, 20, 6, (809-819), (2009).
- C. Michael Gibson, Yuri B. Pride, Philip E. Aylward, Jacques J. Col, Shaun G. Goodman, Dietrich Gulba, Mijo Bergovec, Vijayalakshmi Kunadian, Cafer Zorkun, Jacqueline L. Buros, Sabina A. Murphy, Elliott M. Antman, Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-008-0264-4, 27, 1, (11-17), (2008).
- Ali J. Olyaei, Andrew Whelton, Til Sturmer, George A. Porter, Non-steroidal anti-inflammatory drugs, Clinical Nephrotoxins, 10.1007/978-0-387-84843-3, (419-457), (2008).
- Jamin Akimaliev, Ishimby Sodonbekov, Igor Belolipov, Moul Dey, Salohutdin Zakirov, Ilya Raskin, Anarbek Akimaliev, Anti-inflammatory Botanicals A Case Study Of Genetic Screens As Part Of A Pharmacogenomic Approach, Phytochemicals, 10.1201/9781420061383, (77-87), (2008).
- See more




